Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionNAD+-protein-cysteine ADP-ribosyltransferase activity

PARP6 PARP12 PARP8

1.63e-0561893GO:0140803
GeneOntologyMolecularFunctiontype I interferon receptor binding

IFNA8 IFNA14 IFNA16 IFNA17

1.68e-05171894GO:0005132
GeneOntologyMolecularFunctionprotease binding

FADD BDKRB2 RYR1 PZP ALPI ALPG CD177 APC IL1R1

5.85e-051811899GO:0002020
GeneOntologyMolecularFunctionATPase-coupled transmembrane transporter activity

ABCA1 ATP7B ABCC8 ABCG5 ABCA5 ATP6V0A4 ABCC12

8.04e-051091897GO:0042626
GeneOntologyMolecularFunctionABC-type transporter activity

ABCA1 ABCC8 ABCG5 ABCA5 ABCC12

9.80e-05491895GO:0140359
GeneOntologyMolecularFunctionpentosyltransferase activity

PARP6 PARP12 PARP8 APRT TYMP

1.86e-04561895GO:0016763
GeneOntologyBiologicalProcesscoenzyme A metabolic process

DCAKD MCCC2 PANK1 ALPI ALPG

2.26e-06241895GO:0015936
GeneOntologyBiologicalProcessintermediate filament cytoskeleton organization

KLHL24 ERBIN BFSP2 KRT14 KRT17 KRT32 KRT35 MACF1

3.60e-06991898GO:0045104
GeneOntologyBiologicalProcessintermediate filament-based process

KLHL24 ERBIN BFSP2 KRT14 KRT17 KRT32 KRT35 MACF1

3.88e-061001898GO:0045103
GeneOntologyBiologicalProcesspositive regulation of peptidyl-serine phosphorylation of STAT protein

IFNA8 IFNA14 IFNA16 IFNA17

3.62e-05211894GO:0033141
GeneOntologyBiologicalProcessregulation of peptidyl-serine phosphorylation of STAT protein

IFNA8 IFNA14 IFNA16 IFNA17

6.29e-05241894GO:0033139
GeneOntologyBiologicalProcessintermediate filament organization

KLHL24 BFSP2 KRT14 KRT17 KRT32 KRT35

6.51e-05751896GO:0045109
GeneOntologyBiologicalProcessinterferon-mediated signaling pathway

FADD NR1H2 IFNA8 IFNA14 IFNA16 IFNA17 EPG5

7.82e-051121897GO:0140888
GeneOntologyBiologicalProcessadenine biosynthetic process

GART APRT

8.35e-0521892GO:0046084
GeneOntologyBiologicalProcesspositive regulation of high-density lipoprotein particle assembly

ABCA1 NR1H2

8.35e-0521892GO:0090108
GeneOntologyBiologicalProcessserine phosphorylation of STAT protein

IFNA8 IFNA14 IFNA16 IFNA17

1.18e-04281894GO:0042501
GeneOntologyBiologicalProcessprotein auto-ADP-ribosylation

PARP6 PARP12 PARP8

1.18e-04111893GO:0070213
DomainARM-type_fold

IFT172 TRRAP FOCAD INSC PI4KA ANKAR TAF6 HEATR5B DOCK2 NCAPD3 NOC3L APC NBEA BTAF1 WDFY4 FHOD1 LRBA EIF4G3 XPO7

2.11e-0933919119IPR016024
DomainARM-like

TRRAP INSC ANKAR TAF6 HEATR5B MED12 DOCK2 NCAPD3 NOC3L APC NBEA BTAF1 WDFY4 FHOD1 LRBA XPO7

1.92e-0827019116IPR011989
DomainPH-BEACH_dom

NSMAF NBEA WDFY4 LRBA

7.19e-0781914IPR023362
Domain-

NSMAF NBEA WDFY4 LRBA

7.19e-07819142.30.29.40
DomainPH_BEACH

NSMAF NBEA WDFY4 LRBA

7.19e-0781914PS51783
DomainBEACH

NSMAF NBEA WDFY4 LRBA

1.28e-0691914PS50197
DomainBeach

NSMAF NBEA WDFY4 LRBA

1.28e-0691914PF02138
Domain-

NSMAF NBEA WDFY4 LRBA

1.28e-06919141.10.1540.10
DomainBeach

NSMAF NBEA WDFY4 LRBA

1.28e-0691914SM01026
DomainBEACH_dom

NSMAF NBEA WDFY4 LRBA

1.28e-0691914IPR000409
Domain-

TRRAP INSC ANKAR TAF6 HEATR5B MED12 NCAPD3 APC BTAF1 WDFY4 FHOD1 LRBA

3.16e-06222191121.25.10.10
DomainInterferon

IFNA8 IFNA14 IFNA16 IFNA17

2.27e-05171914PF00143
DomainINTERFERON_A_B_D

IFNA8 IFNA14 IFNA16 IFNA17

2.27e-05171914PS00252
DomainInterferon_alpha/beta/delta

IFNA8 IFNA14 IFNA16 IFNA17

2.27e-05171914IPR000471
DomainIFabd

IFNA8 IFNA14 IFNA16 IFNA17

2.27e-05171914SM00076
DomainKeratin_I

BFSP2 KRT14 KRT17 KRT32 KRT35

8.34e-05441915IPR002957
DomainDUF1088

NBEA LRBA

1.04e-0421912IPR010508
DomainDUF1088

NBEA LRBA

1.04e-0421912PF06469
DomainABC_tran

ABCA1 ABCC8 ABCG5 ABCA5 ABCC12

1.27e-04481915PF00005
DomainABC_TRANSPORTER_2

ABCA1 ABCC8 ABCG5 ABCA5 ABCC12

1.27e-04481915PS50893
DomainABC_TRANSPORTER_1

ABCA1 ABCC8 ABCG5 ABCA5 ABCC12

1.40e-04491915PS00211
DomainABC_transporter-like

ABCA1 ABCC8 ABCG5 ABCA5 ABCC12

1.55e-04501915IPR003439
DomainAlk_phosphatase

ALPI ALPG

6.16e-0441912PF00245
DomainAlkaline_phosphatase_AS

ALPI ALPG

6.16e-0441912IPR018299
Domain3HC_DH_C

CRYL1 HADHA

6.16e-0441912IPR006108
Domain3HCDH

CRYL1 HADHA

6.16e-0441912PS00067
Domain3HCDH

CRYL1 HADHA

6.16e-0441912PF00725
DomainAlkaline_phosphatase

ALPI ALPG

6.16e-0441912IPR001952
Domain3-OHacyl-CoA_DH_NAD-bd

CRYL1 HADHA

6.16e-0441912IPR006176
Domain3-OHacyl-CoA_DH_CS

CRYL1 HADHA

6.16e-0441912IPR006180
Domain3HCDH_N

CRYL1 HADHA

6.16e-0441912PF02737
DomainalkPPc

ALPI ALPG

6.16e-0441912SM00098
DomainALKALINE_PHOSPHATASE

ALPI ALPG

6.16e-0441912PS00123
DomainPoly(ADP-ribose)pol_cat_dom

PARP6 PARP12 PARP8

6.44e-04171913IPR012317
DomainPARP_CATALYTIC

PARP6 PARP12 PARP8

6.44e-04171913PS51059
DomainPARP

PARP6 PARP12 PARP8

6.44e-04171913PF00644
Domain-

PARP6 PARP12 PARP8

6.44e-041719133.90.228.10
DomainFilament

BFSP2 KRT14 KRT17 KRT32 KRT35

8.00e-04711915SM01391
DomainPrefoldin

KIF4A RB1CC1 KRT14 KRT17 KRT35

8.53e-04721915IPR009053
DomainIF

BFSP2 KRT14 KRT17 KRT32 KRT35

8.53e-04721915PS00226
DomainABC_transporter_CS

ABCA1 ABCC8 ABCA5 ABCC12

8.75e-04421914IPR017871
DomainFilament

BFSP2 KRT14 KRT17 KRT32 KRT35

9.08e-04731915PF00038
DomainDUF4704

NBEA LRBA

1.02e-0351912IPR031570
DomainDUF4704

NBEA LRBA

1.02e-0351912PF15787
DomainIF

BFSP2 KRT14 KRT17 KRT32 KRT35

1.09e-03761915IPR001664
DomainPH_BEACH

NBEA LRBA

1.52e-0361912PF14844
DomainPAK_BD

PAK4 PAK1

1.52e-0361912IPR033923
Domain-

IFNA8 IFNA14 IFNA16 IFNA17

1.69e-035019141.20.1250.10
DomainWGR_domain

PARP6 PARP12 PARP8

1.82e-03241913IPR008893
Domain4_helix_cytokine_core

IFNA8 IFNA14 IFNA16 IFNA17

1.82e-03511914IPR012351
PathwayKEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

2.37e-05171464M47564
PathwayKEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

3.02e-05181464M47539
PathwayBIOCARTA_IFNA_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

3.79e-05191464MM1571
PathwayKEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

3.79e-05191464M47450
PathwayKEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

4.70e-05201464M47617
PathwayKEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

5.76e-05211464M47909
PathwayBIOCARTA_IL1R_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17 IL1R1

6.17e-05411465MM1493
PathwayKEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

6.99e-05221464M47897
PathwayKEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

6.99e-05221464M47616
PathwayKEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

8.39e-05231464M47452
PathwayREACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING

IFNA8 IFNA14 IFNA16 IFNA17

8.39e-05231464MM15634
PathwayKEGG_ABC_TRANSPORTERS

ABCA1 ABCC8 ABCG5 ABCA5 ABCC12

8.73e-05441465M11911
PathwayREACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY

ITGB4 KRT14 MEGF6

8.73e-0591463MM15117
PathwayKEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

9.99e-05241464M47576
PathwayKEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

9.99e-05241464M47782
PathwayKEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

9.99e-05241464M47908
PathwayREACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING

IFNA8 IFNA14 IFNA16 IFNA17

1.38e-04261464M982
PathwayBIOCARTA_CYTOKINE_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

1.86e-04281464MM1378
PathwayREACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION

IFNA8 IFNA14 IFNA16 IFNA17

2.45e-04301464M936
PathwayREACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS

DCAKD MCCC2 PANK1 PARP6 MOCS1 PARP8 NFS1

2.48e-041201467MM14771
PathwayWP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY

IFNA8 IFNA14 IFNA16 IFNA17

2.79e-04311464M39897
PathwayKEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

2.79e-04311464M47964
PathwayREACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS

DCAKD MCCC2 PANK1 PARP6 MOCS1 PARP8 NFS1

3.51e-041271467M27093
PathwayBIOCARTA_INFLAM_PATHWAY

IFNA8 IFNA14 IFNA16 IFNA17

3.58e-04331464MM1379
PathwayREACTOME_INTERFERON_ALPHA_BETA_SIGNALING

IFNA8 IFNA14 IFNA16 IFNA17

4.02e-04341464MM15631
PathwayREACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES

IFNA8 IFNA14 IFNA16 IFNA17

4.50e-04351464M48246
PathwayKEGG_REGULATION_OF_AUTOPHAGY

IFNA8 IFNA14 IFNA16 IFNA17

4.50e-04351464M6382
PathwayWP_IRONSULFUR_CLUSTER_BIOGENESIS

HSPA9 NFS1 NARF

4.52e-04151463M48050
PathwayREACTOME_RSV_HOST_INTERACTIONS

MED24 MED12 IFNA8 IFNA14 IFNA16 IFNA17

5.36e-04981466M48247
PathwayWP_INTERFERONMEDIATED_SIGNALING

IFNA8 IFNA14 IFNA16 IFNA17

5.59e-04371464M39785
PathwayWP_INTEGRINMEDIATED_CELL_ADHESION

PAK4 ITGA2B ITGB4 RAP1B MYLK2 PAK1

6.63e-041021466M39577
PathwayWP_INTEGRINMEDIATED_CELL_ADHESION

PAK4 ITGA2B ITGB4 RAP1B MYLK2 PAK1

6.63e-041021466MM15830
PathwayWP_CYTOKINES_AND_INFLAMMATORY_RESPONSE

IFNA8 IFNA14 IFNA16 IFNA17

6.85e-04391464MM15914
PathwayKEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY

FADD IFNA8 IFNA14 IFNA16 IFNA17

8.37e-04711465M15913
PathwayWP_CYTOSOLIC_DNASENSING_PATHWAY

FADD IFNA8 IFNA14 IFNA16 IFNA17

9.49e-04731465M39837
PathwayREACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS

MOCS1 NFS1

1.04e-0351462MM15649
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

DCAKD ZBTB16 OBSCN MCCC2 TRRAP ERBIN SH3BP4 DFFB INTS2 PTPRR PTPRS ABCC8 ANKAR DCLK2 NOTCH2 NSMAF POLR1A ANK3 NPEPPS HECTD4 BTAF1 TESMIN MEGF6 TTC21B MACF1 LRBA EIF4G3 PCNT XPO7 KLHL26

1.30e-0914891953028611215
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

TRPM7 KIF4A MCCC2 ERBIN ADD1 SH3BP4 PI4KA SEC24B VPS13A HSPA9 NOTCH2 KRT14 KRT17 ANK3 NOC3L APC PCDHB2 NBEA LRBA EIF4G3 XPO7

3.39e-097771952135844135
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

DCAKD PAK4 RB1CC1 ERBIN PTPRC PTPRR PTPRS FDFT1 PI4KA SYNE2 SEC24B VPS13A VAT1 KRT14 KRT17 ANK3 NOC3L NBEA HADHA NUP93 G6PD PHLPP2 PCNT NIN

6.23e-0910491952427880917
Pubmed

Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses.

DOCK2 IFNA8 IFNA14 IFNA16 IFNA17

6.53e-0913195522431588
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

REPS1 DCTN5 GART KIF4A PRPF6 MCCC2 ERBIN ADD1 SH3BP4 SEC24B MED12 HSPA9 PARP12 DSTN NPEPPS ASCC1 APC APRT CRYL1 EEF1D IGFBP4 PAK1 CCDC120 HADHA NUP93 G6PD

9.25e-0912471952627684187
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

RAPGEF6 ZBTB16 UBAP2 TRPM7 PAK4 DYRK4 ERBIN SH3BP4 PI4KA SYNE2 SEC24B DCLK2 WNK4 NOTCH2 PARP8 APC MYLK2 MACF1 NUP93 EIF4G3 SPATA13

2.00e-088611952136931259
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

TRPM7 PIEZO1 PAK4 PRPF6 EXT2 MCCC2 RB1CC1 ERBIN ADD1 SH3BP4 FDFT1 PI4KA SYNE2 VPS13A TTC13 HSPA9 NOTCH2 ANK3 NOC3L ASCC1 NVL NFS1 MACF1 PKN2 HADHA EIF4G3 PCNT NIN

2.09e-0814871952833957083
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

GART MCCC2 RYR1 PACS2 VAT1 DOCK2 DSTN ANK3 KRT32 NPEPPS APRT CYRIB EPG5 EEF1D MACF1 HADHA LRBA G6PD HYDIN MYO16

3.42e-088071952030575818
Pubmed

HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells.

IFNA8 IFNA14 IFNA16 IFNA17 CLEC4C

5.74e-0819195517360657
Pubmed

Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.

IFT172 HEATR5B APC DNAH17 MACF1

7.62e-0820195521689717
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

RAPGEF6 UBAP2 REPS1 PAK4 GART KIF4A ERBIN ADD1 SEC24B TAF6 HSPA9 PARP12 NOC3L BTAF1 FHOD1 MACF1 PKN2 LRBA EIF4G3 G6PD PCNT

7.91e-089341952133916271
Pubmed

HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells.

IFNA8 IFNA14 IFNA16 IFNA17 CLEC4C

1.28e-0722195523100517
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

GART KIF4A PRPF6 TRRAP SYNE2 MED12 HSPA9 POLR1A NPEPPS NOC3L NVL MACF1 HADHA NUP93 EIF4G3 PCNT XPO7

1.93e-076531951722586326
Pubmed

Large-scale mapping of human protein-protein interactions by mass spectrometry.

PAK4 GART KIF4A PRPF6 EXT2 RB1CC1 TRRAP SH3BP4 DFFB PTPRS FDFT1 ALPI DSTN KRT32 KRT35 NPEPPS APRT EEF1D HADHA NUP93 LRBA EIF4G3 SNRPG XPO7

2.69e-0712841952417353931
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

RAPGEF6 REPS1 PIEZO1 OBSCN TRRAP ITGB4 RYR1 SH3BP4 FOCAD PRR12 PTPRS PI4KA MED12 NOTCH2 HECTD4 GRID1 BTAF1 CCDC142 MEGF6 LRBA SPATA13 PCNT

3.07e-0711051952235748872
Pubmed

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis.

IFNA8 IFNA14 IFNA16 IFNA17

3.07e-0711195418835032
Pubmed

High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor.

IFNA8 IFNA14 IFNA16 IFNA17

3.07e-071119546444699
Pubmed

Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha.

IFNA8 IFNA14 IFNA16 IFNA17

3.07e-0711195410448195
Pubmed

IFN-alpha can both protect against and promote the development of type 1 diabetes.

IFNA8 IFNA14 IFNA16 IFNA17

3.07e-0711195419120292
Pubmed

Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus.

IFNA8 IFNA14 IFNA16 IFNA17

3.07e-071119548389790
Pubmed

Genome wide study of maternal and parent-of-origin effects on the etiology of orofacial clefts.

SH3BP4 PAK1 SPATA13 KLHL26

3.07e-0711195422419666
Pubmed

The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization.

IFNA8 IFNA14 IFNA16 IFNA17

3.07e-071119543456887
Pubmed

Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression.

IFNA8 IFNA14 IFNA16 IFNA17

3.07e-0711195436681180
Pubmed

Type I interferon dependence of plasmacytoid dendritic cell activation and migration.

IFNA8 IFNA14 IFNA16 IFNA17

3.07e-0711195415795237
Pubmed

Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration.

IFNA8 IFNA14 IFNA16 IFNA17

3.07e-071119549794439
Pubmed

Recombinant rabies virus expressing IFNα1 enhanced immune responses resulting in its attenuation and stronger immunogenicity.

IFNA8 IFNA14 IFNA16 IFNA17

3.07e-0711195425310498
Pubmed

Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane).

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195416565497
Pubmed

Regulation of effector and memory T-cell functions by type I interferon.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195421320124
Pubmed

MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195433123150
Pubmed

A novel anti-viral role for STAT3 in IFN-α signalling responses.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195427988795
Pubmed

Evolution of the interferon alpha gene family in eutherian mammals.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195417512142
Pubmed

IFN-alpha-mediated suppression of low-affinity FC(epsilon) receptors on Peyer's patch lymphocytes and augmentation of soluble CD23: implications for IgE responses.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219548656058
Pubmed

Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219541886773
Pubmed

The physical separation of Lps and Ifa loci in BXH recombinant inbred mice.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219542572648
Pubmed

Developmental control of IFN-alpha expression in murine embryos.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219547925651
Pubmed

The role of type 1 interferons in coagulation induced by gram-negative bacteria.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195432016282
Pubmed

Multiple pathways of interferon-induced gene expression in murine macrophages.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219547684767
Pubmed

Structure and expression of cloned murine IFN-alpha genes.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219546188104
Pubmed

Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195426277892
Pubmed

Mapping of murine interferon-alpha genes to chromosome 4.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219546689487
Pubmed

Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195418716002
Pubmed

Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195416611902
Pubmed

Obesity worsens the outcome of influenza virus infection associated with impaired type I interferon induction in mice.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195430967261
Pubmed

Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195422912583
Pubmed

The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195423747509
Pubmed

Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195417434974
Pubmed

Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195418937499
Pubmed

Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219543758677
Pubmed

GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195419406830
Pubmed

Mapping the genetic region coding for herpes simplex virus resistance to mouse interferon alpha/beta.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219548245849
Pubmed

AAV2-mediated combined subretinal delivery of IFN-α and IL-4 reduces the severity of experimental autoimmune uveoretinitis.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195422685550
Pubmed

Sequence and expression of a novel murine interferon alpha gene--homology with enhancer elements in the regulatory region of the gene.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219543017340
Pubmed

Interferon-alpha/beta genes are up-regulated in murine brain astrocytes after infection with Theiler's murine encephalomyelitis virus.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195420038206
Pubmed

Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219548304945
Pubmed

The virus-induced factor VIF differentially recognizes the virus-responsive modules of the mouse IFNA4 gene promoter.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195411846978
Pubmed

Identification of distal silencing elements in the murine interferon-A11 gene promoter.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219548760352
Pubmed

Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219541422836
Pubmed

Role of interferons in the regulation of cell proliferation, differentiation, and development.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219547530016
Pubmed

Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195417277125
Pubmed

Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219549794206
Pubmed

Isolation and mapping of four new DNA markers from mouse chromosome 4.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219541360280
Pubmed

Characterization of murine interferon-alpha 12 (MuIFN-alpha12): biological activities and gene expression.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195417451966
Pubmed

Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-0712195425897172
Pubmed

A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219548672140
Pubmed

Interferon-alpha/beta can impede development of carcinogen-induced squamous-cell tumors in the esophagus of C57B1 mice.

IFNA8 IFNA14 IFNA16 IFNA17

4.58e-071219547601556
Pubmed

Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN.

PTPRC IFNA8 IFNA14 IFNA16 IFNA17

4.66e-0728195517277142
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

RAPGEF6 UBAP2 REPS1 KIF4A MCCC2 TRRAP ERBIN ADD1 SEC24B TAF6 MED12 ANK3 RFX1 PKN2 LRBA

5.69e-075491951538280479
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

UBAP2 ANKS1B KIF4A ERBIN ADD1 PTPRS PI4KA SYNE2 HSPA9 DSTN ANK3 NPEPPS HECTD4 APC NBEA CYRIB PAK1 MACF1 SPATA13 PCNT

5.71e-079631952028671696
Pubmed

Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195412930842
Pubmed

Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319542014240
Pubmed

An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195418005734
Pubmed

Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195412050368
Pubmed

Isolation and bacterial expression of a murine alpha leukocyte interferon gene.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319546094686
Pubmed

Segregation of restriction fragment length polymorphism in an interspecies cross of laboratory and wild mice indicates tight linkage of the murine IFN-beta gene to the murine IFN-alpha genes.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319542993652
Pubmed

Isolation and characterization of a novel interferon-alpha-encoding gene, IFN-alpha 11, within a murine IFN cluster.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319541655578
Pubmed

Isolation and characterization of a functional murine interferon alpha gene which is not expressed in fibroblasts upon virus induction.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319542471809
Pubmed

IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195421263073
Pubmed

Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319548438572
Pubmed

Interferon alpha promotes caspase-8 dependent ultraviolet light-mediated keratinocyte apoptosis via interferon regulatory factor 1.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195438660315
Pubmed

Interferon-alpha and -gamma differentially reduce rapid immature T-cell death by contact with HIV-1 carrier cell clones in vitro.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319549343822
Pubmed

Evidence for a different susceptibility of primate lentiviruses to type I interferons.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195423255800
Pubmed

Distinction of mouse interferon-alpha subtypes by polymerase chain reaction utilizing consensus primers and type-specific oligonucleotide probes.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319547523540
Pubmed

Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195419635904
Pubmed

Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195419706714
Pubmed

Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor control.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195423804712
Pubmed

Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319543973562
Pubmed

Organization, structure and expression of murine interferon alpha genes.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319542987810
Pubmed

Anti-retroviral effects of type I IFN subtypes in vivo.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195419130550
Pubmed

Type I IFN protects against antigen-induced arthritis.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195421469099
Pubmed

HIV-1 Gag-virus-like particles inhibit HIV-1 replication in dendritic cells and T cells through IFN-α-dependent upregulation of APOBEC3G and 3F.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195422739040
Pubmed

Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195420065291
Pubmed

Effects of IFN alpha on late stages of HIV-1 replication cycle.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319549865497
Pubmed

Obstruction of HIV-1 particle release by interferon-alpha occurs before viral protease processing and is independent of envelope glycoprotein.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-071319549181467
Pubmed

Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195417723216
Pubmed

Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195420427526
Pubmed

Sequencing and bacterial expression of a novel murine alpha interferon gene.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195418726328
Pubmed

Distinct signature type I interferon responses are determined by the infecting virus and the target cell.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195418572754
Pubmed

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.

IFNA8 IFNA14 IFNA16 IFNA17

6.59e-0713195415723075
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

GART KIF4A PRPF6 MCCC2 TRRAP ERBIN PI4KA SEC24B MED12 HSPA9 PARP12 DSTN POLR1A NPEPPS NOC3L ATL3 AARSD1 EEF1D FHOD1 MACF1 PKN2 HADHA NUP93 G6PD

6.83e-0713531952429467282
Pubmed

The interferon system. A bird's eye view of its biochemistry.

IFNA14 IFNA16 IFNA17

6.91e-07419531371992
CytobandEnsembl 112 genes in cytogenetic band chr17q21

DCAKD EME1 ITGA2B MED24 WNK4 VAT1 KRT14 KRT17 KRT32 KRT35 NPEPPS AARSD1 IGFBP4

1.44e-0747319513chr17q21
Cytoband9p22

IFNA8 IFNA14 IFNA16 IFNA17

3.72e-062519549p22
CytobandEnsembl 112 genes in cytogenetic band chr9p21

FOCAD IFNA8 IFNA14 IFNA16 IFNA17

1.96e-041241955chr9p21
Cytoband5q35.1

GABRP DOCK2 STC2

5.71e-043819535q35.1
GeneFamilyWD repeat domain containing|BEACH domain containing

NSMAF NBEA WDFY4 LRBA

2.50e-07912341230
GeneFamilyKeratins, type I

KRT14 KRT17 KRT32 KRT35

3.68e-05281234608
GeneFamilyGlutamate ionotropic receptor delta type subunits

GRID1 GRID2

4.59e-05212321202
GeneFamilyInterferons

IFNA8 IFNA14 IFNA16 IFNA17

6.33e-05321234598
GeneFamilyZinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases

PARP6 PARP12 PARP8

1.95e-04171233684
GeneFamilyAlkaline phosphatases

ALPI ALPG

2.73e-04412321072
GeneFamilyADAM metallopeptidase domain containing|CD molecules

PDGFRB ITGA2B ITGB4 MELTF PTPRC CD200 CD248 CD177 IL1R1 CLEC4C

3.63e-0439412310471
GeneFamilyProtein tyrosine phosphatases, receptor type

PTPRC PTPRR PTPRS

3.74e-04211233813
GeneFamilyCollagens|Collagen proteoglycans

COL12A1 COL15A1

4.53e-0451232575
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

ITGA2B RB1CC1 RYR1 APC HYDIN MYO16

1.50e-031811236694
GeneFamilyATP binding cassette subfamily C

ABCC8 ABCC12

3.41e-03131232807
GeneFamilyATP binding cassette subfamily A

ABCA1 ABCA5

3.96e-03141232805
GeneFamilyFibronectin type III domain containing

OBSCN ITGB4 PTPRC PTPRS COL12A1

4.77e-031601235555
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

PDGFRB OBSCN PTPRS ADAMTSL3 IL1R1

4.89e-031611235593
CoexpressionLEE_CALORIE_RESTRICTION_NEOCORTEX_DN

ZBTB16 PRPF6 ITGB4 IFNA8 IFNA14 IFNA16 IFNA17 EEF1D

2.40e-07851958MM684
ToppCellnormal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass

MELTF PIGA PRMT9 HEATR5B AARSD1 GMCL1 ABCA5 LRBA CLEC4C

7.91e-0817419592274648b80dd74f3c948a779bba3391095964c34
ToppCell10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue

RAPGEF6 PTPRC SYNE2 VPS13A ANK3 PARP8 NBPF15 MACF1 LRBA

1.11e-071811959f2315414e714ac86211546a935660c4be6e85f1b
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OBSCN LRP1B FREM1 MELTF ADAMTS20 COL12A1 GRID1 HYDIN MYO16

1.28e-0718419592cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OBSCN LRP1B FREM1 MELTF ADAMTS20 COL12A1 GRID1 HYDIN MYO16

1.28e-0718419592b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OBSCN LRP1B FREM1 MELTF ADAMTS20 COL12A1 GRID1 HYDIN MYO16

1.28e-071841959ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

TRPM7 RB1CC1 PTPRC SYNE2 NPEPPS BTAF1 EPG5 MACF1 LRBA

1.53e-071881959ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellCOVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type

ABCA1 HK3 PTPRC CD163L1 DOCK2 TYMP WDFY4 CYRIB MYO1F

2.18e-071961959a753d76d764c181eecb0e17a794a2e7d0ff70136
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ABCA1 RYR1 PTPRC CD163L1 DOCK2 TYMP WDFY4 CYRIB MYO1F

2.28e-0719719598af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCellCOVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type

ABCA1 PTPRC PARP12 DOCK2 PARP8 TYMP CYRIB ST6GALNAC5 MYO1F

2.48e-071991959155b03b859157013e9142e9248551369127d9204
ToppCell10x5'-GI_large-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_large-bowel / Manually curated celltypes from each tissue

RAPGEF6 PIEZO1 SEC24B PZP MED12 APC AARSD1 NBPF15

4.52e-07156195801f2c0c6a936dfb59bc727feef428a906ad2a80b
ToppCellControl-MAIT|World / Disease group and Cell class

ABCA1 TRAV1-2 RAPGEF6 ZBTB16 TMEM64 VAT1 TSGA10 ABCA5

6.31e-0716319580ca4b835936b4f82217cbe57210c1dd90986c1d0
ToppCellfacs-GAT-Fat-18m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AMZ1 RYR1 PTPRC DOCK2 WDFY4 CYRIB MYO1F PAK1

8.29e-0716919587a7416fcbffcf57d19b477d9da091e04e3499524
ToppCellfacs-GAT-Fat-18m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AMZ1 RYR1 PTPRC DOCK2 WDFY4 CYRIB MYO1F PAK1

8.29e-0716919580e1a99cd77edcf32bcb513abd247b2b27409ac63
ToppCellfacs-GAT-Fat-18m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AMZ1 RYR1 PTPRC DOCK2 WDFY4 CYRIB MYO1F PAK1

8.29e-0716919589bbad31ef03078f5aa456f2e1b17b49c91545ff0
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZBTB16 TRPM7 PRPF6 ERBIN COL15A1 MACF1 PKN2 HADHA

1.13e-061761958749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCellfacs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AMZ1 KIF4A RYR1 PTPRC DOCK2 WDFY4 CYRIB PAK1

1.45e-061821958df26388c0c46d1c4775103c8e802937b4d4e7470
ToppCellfacs-Lung-EPCAM-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AMZ1 RYR1 PTPRC DOCK2 WDFY4 CYRIB MYO1F PAK1

1.51e-061831958f524501dec1dccbf44100a61395116e4525bdc89
ToppCellCOVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class

ZBTB16 ERBIN PTPRC SYNE2 PZP PARP8 MYO1F MACF1

1.51e-061831958f593a89b0aa8fffdfa403769916facfd30358521
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM7 LRP1B FREM1 SH3BP4 WNK4 ABCA5 ATP6V0A4 LRBA

1.92e-061891958975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCellLV-08._Macrophage|LV / Chamber and Cluster_Paper

PTPRC CD163L1 DOCK2 PARP8 TYMP WDFY4 CYRIB MYO1F

2.16e-0619219587be12d580aaf2f2f1562203fcad3a44639b8c5a6
ToppCell3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

RAPGEF6 PTPRC SYNE2 BTAF1 MACF1 LRBA PHLPP2

2.24e-061351957ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCellCOVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type

ABCA1 PTPRC CD163L1 DOCK2 TYMP WDFY4 CYRIB MYO1F

2.42e-061951958148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCellCOVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type

ABCA1 HK3 PTPRC DOCK2 TYMP WDFY4 CYRIB MYO1F

2.52e-0619619581b7928f4eee94d4bb6ea410bab68a471dba12979
ToppCellCOVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type

ABCA1 HK3 PTPRC DOCK2 TYMP WDFY4 CYRIB MYO1F

2.52e-0619619587026c1fc33425e5476063d17c79e4b79356a9e01
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SYNE2 VPS13A ANK3 PARP8 BTAF1 ABCA5 MACF1 LRBA

2.82e-061991958f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellTracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ABCA1 HK3 RYR1 PTPRC CD163L1 DOCK2 WDFY4 MYO1F

2.82e-0619919589545ac59c8d75f5747dff86cb511a149dc103b31
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ABCA1 RYR1 PTPRC CD163L1 DOCK2 TYMP WDFY4 MYO1F

2.82e-0619919585ceeed92f831d068ff4bb3994f420002338330e7
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PDGFRB LRP1B ITGB4 GRID1 PHYHD1 SLC12A1 ABCC12 GABBR1

2.92e-0620019587a8160e6477708f22e48c609bf8f43f3715dcb03
ToppCellBrain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type.

PDGFRB BDKRB2 COL12A1 COL15A1 CD248 TYMP IGFBP4 IL1R1

2.92e-0620019583da9441c0f1e242f0d195de47ecd4c24dfdca232
ToppCellBrain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type.

PDGFRB BDKRB2 COL12A1 COL15A1 CD248 TYMP IGFBP4 IL1R1

2.92e-062001958eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue

RAPGEF6 PTPRC SYNE2 ANK3 PARP8 BTAF1 MACF1

5.82e-0615619571545169694f686d28648a68b552c2ae606599d66
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AMZ1 PTPRC DOCK2 WDFY4 FHOD1 MYO1F GABBR1

6.07e-061571957ec433d2fe827abdb647be4176c231b7052482b6f
ToppCellsaliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TTC13 ABCG5 WNK4 TMEM64 NOC3L APRT IGFBP4

6.60e-0615919571dde4d19cc0fde7ebbccb4c31bb845a92206021b
ToppCellSevere-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

ERBIN PTPRC NOTCH2 WDFY4 NBPF15 MACF1 NIN

6.60e-0615919572881b054bbeb479221ee3c38bbd9b0815b123579
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SNPH AMZ1 PAK4 OBSCN RYR1 PAK1 CCDC120

7.16e-061611957ed93cb6c133855a5c244821e1a260aae8ab4df9a
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SNPH AMZ1 PAK4 OBSCN RYR1 PAK1 CCDC120

7.16e-0616119570089d7bb305c592392791862a3341fc92af8f3e2
ToppCellCOVID-CD8-exh_CD4|COVID / Condition, Cell_class and T cell subcluster

TRAV1-2 CD200 KRT17 NFS1 RFX1 AARSD1 KLHL26

8.74e-0616619574ca8c91b03d08489f244898cf9423b9d10348bc8
ToppCellfacs-Lung-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

AMZ1 PTPRC DOCK2 WDFY4 CYRIB MYO1F PAK1

1.06e-0517119574ad28ecfde3d529a09b80be908c446bd5274518e
ToppCellfacs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

AMZ1 RYR1 PTPRC WDFY4 CYRIB MYO1F PAK1

1.10e-051721957eaba10a4d4eaab42ad2e2da65ebb20b50edaf815
ToppCelldroplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AMZ1 RYR1 POLR1A PARP8 WDFY4 ESYT3 PAK1

1.10e-051721957a5344760b10ecdc0101f78b93b8fc0f8107068c5
ToppCellfacs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AMZ1 KIF4A PTPRC DOCK2 WDFY4 CYRIB PAK1

1.14e-051731957513b4d31bcfb269556c6b4cc389865fb12e52c4f
ToppCellAdult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor

PDGFRB OBSCN KIF4A INSC MOCS1 GRID1 ADAMTSL3

1.14e-051731957fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PTPRC SYNE2 PZP RAP1B PARP8 MYO1F MACF1

1.14e-05173195736a471576a9d2325066bb14c2f2cd89c67b92915
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ITGB4 BFSP2 WDFY4 IGFBP4 MEGF6 STC2 CCDC120

1.23e-0517519579a96794df049d8228fea57c1584c160191d36b56
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DOK5 RYR1 MELTF OPN5 COL12A1 COL15A1 MYO16

1.28e-05176195795d5a4fdff1b9c715636684d22e06f8727ac0e7a
ToppCellFetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PTPRC DOCK2 WDFY4 CYRIB MYO1F CLEC4C NIN

1.33e-051771957c5e829bc4594761666d65cace5a9c5d19c16f187
ToppCellfacs-Lung-EPCAM-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RYR1 PTPRC NOTCH2 WDFY4 CYRIB MYO1F PAK1

1.38e-05178195701c90c3952220cc4d6a7ed9c4d575fe4f2f80fd1
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TAF6 KRT17 RFX1 IGFBP4 ABCA5 IL1R1 KLHL26

1.43e-051791957163f5430d72ea0c1b239ea5d21e53be536636d3d
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DOK5 RYR1 MELTF OPN5 COL12A1 COL15A1 MYO16

1.43e-0517919573b0f8781232e1d42b6f8913bc989a14b3f978e79
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TAF6 KRT17 RFX1 IGFBP4 ABCA5 IL1R1 KLHL26

1.43e-0517919570624dd537a68736f4d7b8b4de2c56168ed0e60a9
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HK3 KIF4A SYNE2 NCAPD3 DSTN CD177 NIN

1.53e-051811957566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HK3 KIF4A SYNE2 NCAPD3 DSTN CD177 NIN

1.53e-051811957db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LRP1B PGAP6 PANK1 SH3BP4 WNK4 SLC12A1 ST6GALNAC5

1.59e-051821957041bc819e6cf2618bf86bce8dfe2df673f392ba3
ToppCellBasal|World / shred by cell class for mouse tongue

KLHL24 ABCA1 ITGB4 PTPRS KRT14 IGFBP4 MEGF6

1.65e-051831957c6729a207526ff4aa48176207b9353176f631fea
ToppCellControl-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations)

PTPRC DOCK2 WDFY4 CYRIB MYO1F PAK1 CLEC4C

1.65e-0518319578f9c8e2436f18ea7c265b08e4e149e19cb513a16
ToppCellfacs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AMZ1 KIF4A PTPRC DOCK2 WDFY4 CYRIB PAK1

1.65e-051831957062ec08d66c923f90fee771b1bf8d98bdc7e6c1b
ToppCellControl-APC-like|Control / group, cell type (main and fine annotations)

PTPRC DOCK2 WDFY4 CYRIB MYO1F PAK1 CLEC4C

1.65e-051831957c313ac72cc9fa1583456d452393f61f0a4ca33a8
ToppCellfacs-Lung-24m-Hematologic-myeloid|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

AMZ1 PTPRC NOTCH2 WDFY4 CYRIB MYO1F PAK1

1.71e-051841957c451acfcd8fe28c1f4b1ea334b1129fa84a15c42
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

PKD1L1 ANKS1B FOCAD INTS2 ANKAR CD177 IL1R1

1.77e-051851957e06a784a297f357f3f8e761c24fa70722048ab42
ToppCell390C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

RYR1 FOCAD PACS2 BFSP2 CD177 WDFY4 FHOD1

1.83e-05186195774eb69a52090f9e2426a47e03a1c478ee0cfec18
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDGFRB OBSCN INSC MOCS1 CD248 GRID1 ADAMTSL3

1.89e-0518719578ee3bf885897efd634c3a0567637142a9f55e693
ToppCell390C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

RYR1 FOCAD PACS2 BFSP2 CD177 WDFY4 FHOD1

1.89e-0518719571eed2c1a05e80a7c8f639437c117afe0c18dfb0c
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ZBTB16 PDGFRB OBSCN MOCS1 CD248 GRID1 ADAMTSL3

1.96e-051881957ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM7 FREM1 SH3BP4 WNK4 ABCA5 ATP6V0A4 LRBA

1.96e-051881957bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM7 FREM1 SH3BP4 WNK4 ABCA5 ATP6V0A4 LRBA

1.96e-051881957eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCelldroplet-Trachea-nan-3m-Mesenchymal-mesenchymal_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRB COL12A1 GRID1 ADAMTSL3 IGFBP4 ATP6V0A4

1.96e-051261956c3261ea8726400de87f1c8a5a5134ba2b2884f66
ToppCelltumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass

PDGFRB CD163L1 SYNE2 MOCS1 CD248 GRID1 ADAMTSL3

2.03e-0518919579c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM7 FREM1 SH3BP4 WNK4 ABCA5 ATP6V0A4 LRBA

2.03e-0518919577eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PTPRC PZP CD248 CD177 PARP8 CACNA2D4 KLHL26

2.03e-051891957159b0979c93b7d98aaeeb43fba5983a9f67b9c9d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM7 LRP1B WNK4 SLC12A1 ABCA5 ATP6V0A4 LRBA

2.03e-051891957f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM7 FREM1 SH3BP4 WNK4 ABCA5 ATP6V0A4 LRBA

2.03e-051891957977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCellMesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor

PDGFRB OBSCN DCLK2 MOCS1 CD248 GRID1 ADAMTSL3

2.03e-051891957d7ed96add29f219183c802895fbff519b627f635
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

FDFT1 SYNE2 ANK3 IGFBP4 MACF1 LRBA NIN

2.10e-05190195791ba66d4b56c59523485b17738e93f14bb00afa4
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM7 LRP1B WNK4 SLC12A1 ABCA5 ATP6V0A4 LRBA

2.10e-051901957b94df372bc08de11585b2467dba8c8fffff5cd92
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM7 FREM1 SH3BP4 WNK4 ABCA5 ATP6V0A4 LRBA

2.10e-051901957e252e925600e6457fa6e362a55217f4cffa75cdb
ToppCellLV-08._Macrophage|World / Chamber and Cluster_Paper

PTPRC CD163L1 DOCK2 PARP8 WDFY4 CYRIB MYO1F

2.17e-051911957e7a0bc46ba9ba772636a583f3387748418e18832
ToppCellControl-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations)

ABCA1 RYR1 PTPRC CD163L1 DOCK2 WDFY4 MYO1F

2.32e-051931957a6b3bd01e585e2e3fbe9bf693a2e385773123f8e
ToppCell(1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis

PDGFRB PTPRS INSC CD200 COL12A1 PAK1 SPATA13

2.32e-051931957035eeea9f77c4bf9cd85f07fa791b6c857be76b5
ToppCellCOVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type

PTPRC CD163L1 DOCK2 PARP8 WDFY4 CYRIB MYO1F

2.40e-051941957f09675cd472200363c458952f00d2e41990800ee
ToppCellnucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

HK3 PTPRC NOTCH2 DOCK2 TYMP MYO1F NIN

2.40e-051941957e237384b02be460d44eeada3026a5691c66f6fc1
ToppCellnucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

HK3 PTPRC NOTCH2 DOCK2 TYMP MYO1F NIN

2.40e-0519419570bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO1 ANKS1B LRP1B FREM1 ANK3 ATP6V0A4 LRBA

2.40e-05194195769bff17df4a760ccf081cf52ff04af02c14f448d
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ABCA1 RYR1 PTPRC CD163L1 DOCK2 WDFY4 MYO1F

2.40e-0519419571dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCellT_cells-CD56_dim_CD16+_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

ZBTB16 PDGFRB SYNE2 CYRIB MYO1F EIF4G3 G6PD

2.40e-051941957335c6c2f3f319d4f19eace62f8826a0f40c130f6
ToppCellLA-08._Macrophage|World / Chamber and Cluster_Paper

PTPRC CD163L1 DOCK2 PARP8 TYMP WDFY4 MYO1F

2.40e-051941957c1805572bcc11b1cd29083329d7b5911489fb758
ToppCellcellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PTPRC PRMT9 WDFY4 CYRIB MYO1F PAK1 CLEC4C

2.40e-05194195774d588de2f84a4ef112fd642f7e112a542d5ef11
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Dendritic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PTPRC PRMT9 TYMP WDFY4 CYRIB PAK1 CLEC4C

2.40e-05194195759180fe75be386530f1be668a37e4ada2eb19ddc
ToppCellcellseq-Immune-Immune_Myeloid-pMON-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

HK3 NBPF19 PTPRC NOTCH2 DOCK2 TYMP MYO1F

2.48e-0519519572cb435dae2691e1250e26e59f9b8fb652a0c383e
ToppCellCOVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class

ERBIN PTPRC SYNE2 PZP PARP8 MYO1F MACF1

2.48e-051951957ff7ae62393e1c858a10592db8e6d9f36b8bae396
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ABCA1 RYR1 CD163L1 DOCK2 WDFY4 CYRIB MYO1F

2.48e-051951957247803cf58c6d9c561a52aa34e581188ddad197e
ToppCellcellseq-Immune-Immune_Myeloid-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

HK3 NBPF19 PTPRC NOTCH2 DOCK2 TYMP MYO1F

2.48e-051951957217908cb53016a6cb51f1bc3fc752c8df650df71
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ABCA1 RYR1 PTPRC CD163L1 DOCK2 WDFY4 MYO1F

2.48e-05195195734a9462f4e843f3065cc58c17ad71c1b5b836ae1
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ZBTB16 PDGFRB SYNE2 RAP1B DSTN CYRIB MYO1F

2.56e-0519619578e1ed30256a031bb90dac1f167e074c68efbed74
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 TSGA10 CYRIB CRYL1 SLC12A1 ATP6V0A4 LRBA

2.56e-051961957eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

HK3 RYR1 PTPRC CD163L1 DOCK2 WDFY4 MYO1F

2.56e-0519619574370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ABCA1 EFS FREM1 PZP MACF1 MYO16 SPATA13

2.64e-051971957fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCellFetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

HK3 PTPRC DOCK2 TYMP WDFY4 CYRIB MYO1F

2.64e-05197195748a8169a4d33c6a68d66bcd936861c75cb4b60ef
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PTPRC SYNE2 VPS13A ANK3 BTAF1 MACF1 LRBA

2.64e-05197195757ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCellmild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SYNE2 VPS13A PZP ANK3 ABCA5 LRBA MYO16

2.64e-051971957e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PDGFRB LRP1B PTPRS COL12A1 COL15A1 CD248 IGFBP4

2.64e-0519719573bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ComputationalGenes in the cancer module 68.

KRT14 KRT17 KRT32 KRT35

1.71e-04261184MODULE_68
ComputationalKeratin.

KRT14 KRT17 KRT32 KRT35

1.71e-04261184MODULE_298
Drugglycidamide

EME1 TRPM7 NR1H2 APC GRID2 IGFBP4 IL1R1 G6PD

2.56e-061021938CID000091550
DiseaseColorectal Carcinoma

ABCA1 ATP7B HK3 TRPM7 EFS OBSCN PTPRS ABCC8 VPS13A PZP DSTN CD248 PARP8 APC GRID1 GRID2 ERI2 TYMP ADAMTSL3 GMCL2 ABCA5

3.13e-0970218321C0009402
Diseaseobsolete Mendelian syndromes with cleft lip/palate

SH3BP4 PAK1 SPATA13 KLHL26

1.16e-05231834MONDO_0015335
DiseaseHDL cholesterol change measurement

ABCA1 SYNE2 DCLK2 GRID1

1.38e-05241834EFO_0007805
DiseaseSarcomatoid Renal Cell Carcinoma

LRP1B RYR1 SYNE2 HSPA9 KRT32 APRT PAK1

1.58e-051281837C1266043
DiseaseChromophobe Renal Cell Carcinoma

LRP1B RYR1 SYNE2 HSPA9 KRT32 APRT PAK1

1.58e-051281837C1266042
DiseaseCollecting Duct Carcinoma of the Kidney

LRP1B RYR1 SYNE2 HSPA9 KRT32 APRT PAK1

1.58e-051281837C1266044
DiseasePapillary Renal Cell Carcinoma

LRP1B RYR1 SYNE2 HSPA9 KRT32 APRT PAK1

1.58e-051281837C1306837
DiseaseRenal Cell Carcinoma

LRP1B RYR1 SYNE2 HSPA9 KRT32 APRT PAK1

1.58e-051281837C0007134
DiseaseConventional (Clear Cell) Renal Cell Carcinoma

LRP1B RYR1 SYNE2 HSPA9 KRT32 APRT PAK1

4.03e-051481837C0279702
Diseasehemoglobin A1 measurement

PIEZO1 MELTF PRDM11 PTPRR ABCC8 SYNE2 VPS13A NOTCH2 CYRIB GMCL2 MACF1 PKN2

1.06e-0452018312EFO_0007629
DiseaseEpidermolysis Bullosa Herpetiformis Dowling-Meara

ITGB4 KRT14

1.14e-0431832C0079295
DiseaseEpidermolysis Bullosa Simplex Kobner

ITGB4 KRT14

1.14e-0431832C0079299
DiseaseWeber-Cockayne Syndrome

ITGB4 KRT14

1.14e-0431832C0080333
DiseaseSchizophrenia

ABCA1 RAPGEF6 PDGFRB PGBD1 RB1CC1 TRRAP PI4KA MED12 HSPA9 ANK3 APC GRID1 ADAMTSL3 MYO16 GABBR1 PCNT

1.33e-0488318316C0036341
DiseaseChediak-Higashi syndrome (implicated_via_orthology)

NSMAF WDFY4

2.28e-0441832DOID:2935 (implicated_via_orthology)
DiseaseEpidermolysis Bullosa

ITGB4 KRT14

2.28e-0441832C0014527
Diseasevery low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio

ABCA1 FDFT1 SYNE2 ABCG5 HECTD4 TYW1B MACF1 NUP93

2.57e-042641838EFO_0008317, EFO_0020944
DiseaseColorectal Neoplasms

ABCA1 ATP7B TRPM7 ABCC8 APC GRID1 TYMP ABCA5

3.54e-042771838C0009404
DiseaseEpidermolysis Bullosa Simplex

ITGB4 KRT14

3.78e-0451832C0079298
Diseasehyperinsulinemic hypoglycemia (implicated_via_orthology)

HK3 ABCC8

3.78e-0451832DOID:13317 (implicated_via_orthology)
Diseasesystemic mastocytosis

ABCA1 MOCS1 MEGF6

4.88e-04251833MONDO_0016586
Diseasemean reticulocyte volume

ZBTB16 PIEZO1 TRRAP DFFB PTPRC FDFT1 VPS13A POLR1A NPEPPS NOC3L TYMP CYRIB MYO16 XPO7

4.91e-0479918314EFO_0010701
DiseaseIntellectual Disability

PDGFRB KIF4A TRRAP PRR12 FDFT1 PACS2 TAF6 APC NBEA MACF1

5.09e-0444718310C3714756
Diseasemean corpuscular hemoglobin concentration

ZBTB16 ATP7B PIEZO1 PGAP6 FOCAD PTPRC VPS13A POLR1A HECTD4 TYMP CYRIB MYLK2 MACF1 PKN2 EIF4G3 MYO16 XPO7

5.50e-04110518317EFO_0004528
Diseasepost-operative acute kidney injury, response to surgery

EIF4G3 PHLPP2

5.65e-0461832EFO_0009951, EFO_0009955
Diseasehyperopia

PARP8 GRID1

5.65e-0461832MONDO_0004891
Diseaseobsolete_red blood cell distribution width

KLHL24 PIEZO1 HSD11B1L SYNE2 VPS13A POLR1A HECTD4 MKRN2OS NVL TYMP CYRIB EPG5 GMCL1 ESYT3 FARS2 PKN2 EIF4G3 G6PD MYO16

7.45e-04134718319EFO_0005192
Diseaseepidermolysis bullosa simplex (is_implicated_in)

KLHL24 KRT14

7.87e-0471832DOID:4644 (is_implicated_in)
DiseaseMajor Depressive Disorder

ZBTB16 ATP7B BDKRB2 PTPRR MED12 APRT PCNT

8.39e-042431837C1269683
DiseaseNonorganic psychosis

PTPRC MED12 ANK3 PCNT

9.04e-04691834C0349204
Diseasepantothenate measurement

ABCA1 DFFB

1.05e-0381832EFO_0021034
Diseasenucleotide measurement

ANKS1B SYNE2 DOCK2 PHYHD1

1.12e-03731834EFO_0010513
DiseaseMalignant neoplasm of breast

GABRP ATP7B HK3 OBSCN RB1CC1 PTPRC SYNE2 MED12 NOTCH2 KRT14 APRT EPG5 STC2 PAK1 MACF1 LRBA

1.12e-03107418316C0006142
DiseaseUnipolar Depression

ZBTB16 ATP7B BDKRB2 PTPRR MED12 APRT PCNT

1.21e-032591837C0041696
Diseasesusceptibility to mumps measurement

BDKRB2 PRDM11 CD200 GABBR1

1.23e-03751834EFO_0008404
Diseasesexual dimorphism measurement

ABCA1 RAPGEF6 AMZ1 PGBD1 MED24 BTN1A1 KRT17 CD248 NPEPPS APC NFS1 ADAMTSL3 IGFBP4 MYO1F MACF1 NUP93

1.51e-03110618316EFO_0021796
Diseaseaspartate aminotransferase measurement

ABCA1 RAPGEF6 TRPM7 PIEZO1 OBSCN PTPRC PTPRR VAT1 HECTD4 NOC3L SLC22A1 PKN2 LRBA GABBR1

1.60e-0390418314EFO_0004736
Diseasecystic kidney disease (implicated_via_orthology)

IFT172 TTC21B

1.67e-03101832DOID:2975 (implicated_via_orthology)
Diseaseserum gamma-glutamyl transferase measurement

REPS1 TRPM7 IFT172 PGAP6 LRGUK NOTCH2 NSMAF HECTD4 NOC3L TYW1B SLC22A1 PKN2 LRBA SPATA13

1.77e-0391418314EFO_0004532
DiseaseJeune thoracic dystrophy

IFT172 TTC21B

2.03e-03111832C0265275
DiseaseCleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement

FOCAD ANK3

2.03e-03111832EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175
Diseasesmoking status measurement, chronic obstructive pulmonary disease

AMZ1 MED24 BTN1A1 GABBR1

2.23e-03881834EFO_0000341, EFO_0006527
Diseaseobesity (biomarker_via_orthology)

ABCA1 FADD NR1H2 ABCG5 G6PD

2.28e-031471835DOID:9970 (biomarker_via_orthology)
Diseasewaist-hip ratio, body mass index

ANKS1B DOCK2

2.42e-03121832EFO_0004340, EFO_0004343
Diseaseplatelet crit

ZBTB16 AMZ1 PIEZO1 ITGA2B PANK1 SH3BP4 PTPRC NPEPPS NOC3L MYLK2 EPG5 GMCL2 PKN2 SPATA13

2.56e-0395218314EFO_0007985
Diseasevery low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio

SYNE2 ABCG5 TYW1B MACF1 NUP93 LRBA

2.70e-032221836EFO_0008317, EFO_0020943
DiseaseGastric Adenocarcinoma

TRPM7 PDGFRB TRRAP

2.75e-03451833C0278701
Diseasetriglyceride measurement, very low density lipoprotein cholesterol measurement

ABCA1 FDFT1 SYNE2 TYW1B SLC22A1 MACF1

2.82e-032241836EFO_0004530, EFO_0008317
DiseaseErythrocyte Mean Corpuscular Hemoglobin Test

MYLK2 HADHA

2.85e-03131832C0369183
DiseaseShort Rib-Polydactyly Syndrome

IFT172 TTC21B

2.85e-03131832C0036996
Diseasesmoking status measurement, ulcerative colitis

PARP6 WDFY4

2.85e-03131832EFO_0000729, EFO_0006527
DiseaseFinding of Mean Corpuscular Hemoglobin

MYLK2 HADHA

2.85e-03131832C1261502
Diseasecortisol measurement, response to corticosteroid, response to synacthen

ANKS1B LRP1B

2.85e-03131832EFO_0005843, EFO_0009175, GO_0031960
Diseasegallbladder cancer (is_implicated_in)

LRP1B APC

2.85e-03131832DOID:3121 (is_implicated_in)
Diseasetriglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement

ABCA1 ABCG5 NPEPPS TYW1B MACF1 LRBA

2.89e-032251836EFO_0008317, EFO_0020947
DiseaseSquamous cell carcinoma of esophagus

NOTCH2 KRT14 KRT17 TYMP

2.94e-03951834C0279626
DiseaseSaldino-Noonan Syndrome

IFT172 TTC21B

3.31e-03141832C0036069
DiseaseMajewski Syndrome

IFT172 TTC21B

3.31e-03141832C0024507
Disease5-methyluridine (ribothymidine) measurement

PTPRS TYMP

3.31e-03141832EFO_0020013
DiseasePsychotic Disorders

PTPRC MED12 ANK3 PCNT

3.66e-031011834C0033975
DiseaseGastro-enteropancreatic neuroendocrine tumor

PTPRC NOTCH2

3.81e-03151832C2930967
Diseasevery low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio

ABCA1 FDFT1 ABCG5 TYW1B MACF1 NUP93

3.88e-032391836EFO_0008317, EFO_0020945
Diseasefree cholesterol to total lipids in small HDL percentage

ABCA1 ABCG5 NUP93

3.93e-03511833EFO_0022285
DiseaseParkinson disease

UBAP2 ITGA2B FDFT1 COL12A1 CYRIB MYLK2 DNAH17

4.03e-033211837MONDO_0005180
Diseasesusceptibility to bacterial meningitis measurement

AMZ1 SYS1 ANK3

4.15e-03521833EFO_0008411
Diseaseamygdala volume change measurement

PKD1L1 PARP8

4.34e-03161832EFO_0021490
Diseasesystemic lupus erythematosus

MELTF PTPRC FDFT1 NOTCH2 HECTD4 MKRN2OS WDFY4 IFNA14 IFNA17 SLC12A1 G6PD GABBR1

4.34e-0379918312MONDO_0007915
Diseaselymphocyte count

ZBTB16 UBAP2 AMZ1 PIEZO1 FOCAD PTPRC FDFT1 NOTCH2 NSMAF PARP12 DOCK2 HECTD4 NOC3L NFS1 CYRIB SLC12A1 DNAH17 PKN2

4.50e-03146418318EFO_0004587
DiseaseLiver carcinoma

KIF4A ADD1 FDFT1 NR1H2 PZP HSPA9 COL15A1 APC SLC22A1

4.56e-035071839C2239176
Diseasemelanoma

TRRAP LRP1B MELTF CD163L1 ADAMTS20 PAK1

4.64e-032481836C0025202
DiseaseIschemic stroke, fibrinogen measurement

RAPGEF6 HECTD4 IL1R1

4.86e-03551833EFO_0004623, HP_0002140
Diseaseresponse to radiation, Urinary retention

LRP1B PTPRS

4.89e-03171832GO_0009314, HP_0000016
DiseaseEye Abnormalities

FREM1 APC

4.89e-03171832C0015393
DiseaseNecrotizing Enterocolitis

HSPA9 CRYL1

4.89e-03171832C0520459
Diseaseextrahepatic cholestasis (biomarker_via_orthology)

ABCA1 SLC22A1

4.89e-03171832DOID:13619 (biomarker_via_orthology)
Diseaserespiratory symptom change measurement, response to placebo

FARS2 PKN2

4.89e-03171832EFO_0008344, EFO_0010068
Diseasenon-high density lipoprotein cholesterol measurement

ABCA1 REPS1 ADD1 FDFT1 CD163L1 SYNE2 NPEPPS TYW1B SLC22A1 SNRPG HYDIN

5.12e-0371318311EFO_0005689
Diseasetriglyceride measurement, intermediate density lipoprotein measurement

ABCA1 FDFT1 SYNE2 TYW1B

5.12e-031111834EFO_0004530, EFO_0008595
DiseaseHypercholesterolemia, Familial

ABCA1 ABCG5

5.48e-03181832C0020445
Diseasefibrinogen measurement, factor VII measurement

RAPGEF6 HECTD4 IL1R1

5.64e-03581833EFO_0004619, EFO_0004623
Diseasecoffee consumption measurement

GABRP ADD1 GRID2 FARS2 HYDIN

5.66e-031821835EFO_0006781
Diseasevery low density lipoprotein cholesterol measurement

ABCA1 FDFT1 ABCG5 TYW1B SLC22A1 MYO1F

5.81e-032601836EFO_0008317
Diseaseasthma, response to diisocyanate

RAPGEF6 ZBTB16 LRP1B RYR1 COL12A1 NIN

5.92e-032611836EFO_0006995, MONDO_0004979
Diseaseneuroblastoma

DOCK2 PARP8 GRID1 FARS2

5.98e-031161834EFO_0000621
Diseaseinosine measurement

ZBTB16 GMCL2

6.10e-03191832EFO_0010503
Diseasehydrocephalus (implicated_via_orthology)

ADD1 HYDIN

6.10e-03191832DOID:10908 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
VNELSALMEDGRCQV

TTC21B

821

Q7Z4L5
AEAVCDRVAIMVSGQ

ABCA5

1496

Q8WWZ7
IQVEEMSACNISIQG

ERI2

261

A8K979
NIEMVEEGISTCENL

ERBIN

241

Q96RT1
LQICLGDVMTNRVVD

ESYT3

391

A0FGR9
EQMSVQGICADQVKV

EPG5

331

Q9HCE0
GETLCRVVNAIISMN

BDKRB2

126

P30411
IQSISVLGLECEMDV

PRMT9

466

Q6P2P2
LAMCIQALQREVAEE

AMZ1

411

Q400G9
SMQVQENGEICLECT

BTN1A1

151

Q13410
QEAVVKLRVEGMTCQ

ATP7B

141

P35670
VDTDECQIAGVCQQM

CD248

311

Q9HCU0
CGLLANRQSVVMVEE

CALHM3

66

Q86XJ0
EEMIQLGDQEVSELC

ABCA1

201

O95477
VERLVAMNLQECQVA

CFAP46

2491

Q8IYW2
IRVVNIEGVDSNMCC

AARSD1

196

Q9BTE6
GMLVLLSEEEIQQTC

ASCC1

211

Q8N9N2
IGLAAQCLEAVIEMQ

CCDC142

171

Q17RM4
QCLEAVIEMQLRALG

CCDC142

176

Q17RM4
EAQEEFLRVLGSMCQ

DFFB

181

O76075
EMCEVGQVCQETLLL

CD177

236

Q8N6Q3
MNIAEVVCRQLECGS

CD163L1

721

Q9NR16
LDVQDVNVAITMCVL

HSD11B1L

196

Q7Z5J1
MASGVQVADEVCRIF

DSTN

1

P60981
CQQVGEAVLENARLM

BFSP2

161

Q13515
MAQLEACVRSIQLDG

EEF1D

211

P29692
RLKGVGQVVEEMCDQ

ADAMTS20

1501

P59510
MNAACELLGRLQAEV

APRT

136

P07741
LIQQCGETMKETVNV

GMCL1

196

Q96IK5
QGENMFLRCVSELVI

NUP93

561

Q8N1F7
VDAQQCMLEILDTAG

RAP1B

46

P61224
EAMQSLELCGNEVVE

PZP

881

P20742
MAEQVALSRTQVCGI

G6PD

1

P11413
MQGLCIELNDFIVAL

NVL

546

O15381
GTCVVFVQVMDLNDN

PCDHB2

331

Q9Y5E7
VNVMNCIRVLCIGNE

ANKAR

841

Q7Z5J8
QVLLEAGMDVSCQTE

ANKS1B

211

Q7Z6G8
ALDQMIASCGRLVNE

RB1CC1

371

Q8TDY2
VEGMVAELINCQADV

NOTCH2

1956

Q04721
IATGAQVVDLLVSMC

PARP8

551

Q8N3A8
MNDLEACVIQEVGVE

IFNA14

116

P01570
MGIIAVANDTNSCEL

LRP1B

2451

Q9NZR2
LLVVIFMNGNCATEE

MAGEB6

291

Q8N7X4
VVGLGAACEVAQQEM

NFS1

301

Q9Y697
VSGVECMIIANDATV

MCCC2

126

Q9HCC0
VGLMEEVVCNIQKEI

GMEB1

266

Q9Y692
FLHEQVECVQEGVTM

MYO16

811

Q9Y6X6
MIGSVEEQLAQLRCE

KRT14

376

P02533
QACQPAVEMALEDVN

GABBR1

186

Q9UBS5
CMITNVEAQLAEIRA

KRT32

356

Q14532
ELISQMLQVNVEARC

DCLK2

626

Q8N568
MLQVNVEARCTAGQI

DCLK2

631

Q8N568
CLGMRLAQLSQEDVV

CCDC120

196

Q96HB5
AVIQALDGEMRNAVC

FDFT1

56

P37268
LNDLEACVMQEERVG

IFNA1;

116

P01562
EACELMNQGILALVS

GRID2

81

O43424
VDTMVFVRQICDGIL

MYLK2

381

Q9H1R3
FVVQNITVCEGQMKE

FREM1

1151

Q5H8C1
IMSLLIQIGQVCASD

INTS2

1121

Q9H0H0
MTINLAVCDLGISVV

OPN5

71

Q6U736
VGDDCRQDMLALQII

PI4KA

1851

P42356
IQEGESINCMVDLLE

LRBA

86

P50851
QDQMAQVFEGLCGVV

MED12

941

Q93074
VLQMECVGTRINDIS

DOK5

106

Q9P104
QCMITNVEAQLAEIR

KRT35

356

Q92764
EIEEISGLEMCNNLI

LRGUK

226

Q96M69
MRNETVVVACVNAAS

PGAP6

411

Q9HCN3
NQIVMNCADIDIITA

NPEPPSL1

91

A6NEC2
QNMLRVLIDGVECSD

PACS2

846

Q86VP3
QILTGCDEVLEMLQQ

HECTD4

496

Q9Y4D8
RIEELTCGGMVEQVQ

HECTD4

1231

Q9Y4D8
DALMVLEVCQAVSQR

HK3

821

P52790
VGIQKTDNIAIEMCE

GTPBP8

201

Q8N3Z3
QVEIKVCQGEREMAG

HSPA9

481

P38646
ELLAAGCQRESIVVM

ITGB4

66

P16144
QEGVMSVLTVCQRQL

PCNT

2016

O95613
QDRIVEVNGVCMEGK

SLC9A3R1

196

O14745
VNSAVAMGEVILAVC

MACF1

6826

Q9UPN3
VNCVVMRGLNEDELL

MOCS1

216

Q9NZB8
ENVCMIFNAGELTLV

IFT172

406

Q9UG01
EGVVDALSIVCQLRM

PTPRR

611

Q15256
CVAMSSLGVIEAVAQ

PTPRS

311

Q13332
VMAAVVLCTAQVQVV

CD200

21

P41217
MAQAGVVGEVTQVLC

PARP12

1

Q9H0J9
IEAAGCMRQLVVQQA

OBSCN

1306

Q5VST9
GCQDIATQLISNMDI

ALPI

201

P09923
GCQDIATQLISNMDI

ALPG

201

P10696
MDEGQIAAVCRECLQ

PAK1

361

Q13153
GENEVEQLACIMEVL

DYRK4

306

Q9NR20
CEQNEMLSIGIEEVF

HYDIN

1316

Q4G0P3
VMVCALQELGSLVQS

HEATR5B

416

Q9P2D3
LVEINGILAEAMECF

KLHL24

106

Q6TFL4
DCVQDVLGAAVFLQM

KLHL26

131

Q53HC5
IGSVEEQLAQLRCEM

KRT17

346

Q04695
TTQRNVEVIMCVCAE

DOCK2

441

Q92608
IEALACVMEQLDVGI

BTAF1

1166

O14981
AVARQVCEQLISGQM

COL12A1

2906

Q99715
MVFDQECDLSGQVEV

DNAH17

1641

Q9UFH2
FQQLGCAVIDVDVMA

DCAKD

21

Q8WVC6
CNQAIMLISDGAVED

CACNA2D4

396

Q7Z3S7
RSCQMNLVADLVQEV

FADD

166

Q13158
TGLDCMTANQIVVLL

ABCG5

221

Q9H222
EAVMTSCQGLENETI

ANK3

3746

Q12955
QEMVQCVTELAGQAL

EFS

536

O43281
LEVVAQLFNCMVGLL

ATL3

466

Q6DD88
IVMNDCIIRGDLANV

DCTN5

41

Q9BTE1
FVNEAVMCLQEGILA

HADHA

681

P40939
CASDIIQENGVQLIM

INSC

451

Q1MX18
DGCLNVIDVQTGMLI

NSMAF

826

Q92636
VACMAAAIDTAVEQE

KIF4A

481

O95239
VQEACDLMTQGILAL

GRID1

76

Q9ULK0
IQEAVEGAMHIQECV

CRYL1

81

Q9Y2S2
NEETVSFCLRVMVGV

CYRIB

246

Q9NUQ9
LNDLESCVMQEVGVI

IFNA8

116

P32881
GALQTMECRCVIEAQ

EME1

271

Q96AY2
VGMEQLVQNATFRCI

FHOD1

806

Q9Y613
MIVQGEEVTLLVNCE

COL15A1

166

P39059
AGVDVQAAICLLANM

SEC24B

1011

O95487
GITIAIQMICLVNAE

SLC22A1

441

O15245
DVVGCMIDLTENTII

RYR1

1146

P21817
EAMQCVEELNAQGLL

EIF4G3

1241

O43432
MEVDLGSQIQLICNV

IL1R1

236

P14778
VCRLAFVDQEEMIGS

PKD1L1

1356

Q8TDX9
NQIVMNCADIDIITA

NPEPPS

91

P55786
LNNLEACVIQEVGME

IFNA17

116

P01571
AEECVAMQQRIGEIV

PHYHD1

26

Q5SRE7
GEEIQQLCLEIMVTQ

FOCAD

1421

Q5VW36
TERMCIQGSQFNVEV

GABRP

16

O00591
VQTVVRQGENITLMC

PDGFRB

221

P09619
ITLMCIVIGNEVVNF

PDGFRB

231

P09619
GAEVVDLLVAMCRAA

PARP6

331

Q2NL67
RMNEEQIAAVCLAVL

PAK4

411

O96013
TNEGVEIVLQCLDVM

NOC3L

596

Q8WTT2
IGSIARMCALNENID

PANK1

526

Q8TE04
VVVNSGAICMVIFNL

OR4A5

196

Q8NH83
EQMILEEFGRCLSQI

TESMIN

481

Q9Y4I5
RIEMEIVNSCEANNG

MEGF6

326

O75095
LVQAVCIALMAVIGE

SYS1

121

Q8N2H4
MGIAQIQEETCQLLT

TAF6

26

P49848
ELCSVMIFEVVEQAG

RAPGEF6

291

Q8TEU7
GEVLQKIDVQESFCM

POLR1A

1291

O95602
NDVVLQIMELCGATR

REPS1

46

Q96D71
CMERIQAEQVDAVTL

MELTF

406

P08582
MDCQGLVVRLIQDFV

SH3BP4

831

Q9P0V3
VLEQQLVGCQAMLTE

SYNE2

4271

Q8WXH0
MLQSGCQVIGEEEVE

NIN

1031

Q8N4C6
SLEEQQVCMAVDIGR

NBPF15

316

Q8N660
SLEEQQVCMAVDIGR

NBPF19

316

A0A087WUL8
LEQQCVGLAVDMDEI

NBPF19

636

A0A087WUL8
ILEQQCVGLAVDMDE

NBPF19

1611

A0A087WUL8
LEQQCVGLAVDMDEI

NBPF19

1856

A0A087WUL8
EQQCVGLAVDMDEIE

NBPF19

2101

A0A087WUL8
ILEQQCVGLAVDMDE

NBPF19

2831

A0A087WUL8
LEQQCVGLAVDMDEI

NBPF19

3076

A0A087WUL8
EQQCVGLAVDMDEIE

NBPF19

3321

A0A087WUL8
CEAIVDVMVNLQFTL

RFX1

616

P22670
TCQAVMRAVIGIGIE

PRPF6

521

O94906
ACVTQEVGVEEIALM

IFNA16

121

P05015
ISQMVDNIIIACGGI

NBEA

1386

Q8NFP9
VVAILAAACMLQLDG

GMCL2

181

Q8NEA9
EAGMREQCVLSEEQI

NR1H2

151

P55055
ECLAQTNAAVGDMVT

PRDM11

41

Q9NQV5
ERMCADVLQQTATQI

MED24

671

O75448
CVVRDATGNMNDTII

SLC12A1

436

Q13621
GSQIDQTECVIRMND

ST6GALNAC5

111

Q9BVH7
GQGVCMELAEIEAIQ

IGFBP4

96

P22692
CTVVQCDLQEMARGQ

ITGA2B

916

P08514
EVTVQEMRCVFGVLL

PGBD1

451

Q96JS3
LEVRLMGCQDILENV

PKN2

331

Q16513
AEDLGQEEVVQQCMR

PRR12

1996

Q9ULL5
EAGVQASCMQERAIQ

SNPH

301

O15079
DIVANILCIIMAAIG

ABCC12

126

Q96J65
EMTAGQICNLVAIDT

ABCC8

411

Q09428
SQVLCGVVMDRSLVQ

ADD1

521

P35611
GLQAIAELLQVDCEM

APC

471

P25054
CSVMGADLVVINTRE

CLEC4C

111

Q8WTT0
VCEDVAVRNNVIIVM

NCAPD3

951

P42695
MAIVEAASCGLQVVS

PIGA

316

P37287
CRLLQQMIDIAIDGF

SPATA13

361

Q96N96
VDAQQCMLEILDTAG

nan

46

A6NIZ1
RAQVELNAAIVACEM

TMEM64

331

Q6YI46
MEVTGKNQDECIVAL

UBAP2

61

Q5T6F2
QELICVADRLGSLMQ

TTC13

501

Q8NBP0
DMNVVDIQVNLIVGC

VPS13A

1141

Q96RL7
GTLCDVVIMVDSQEF

ZBTB16

31

Q05516
ALTFINCVLMAEGRQ

MKRN2OS

156

H3BPM6
LQCTMADVLLEEVQQ

PHLPP2

831

Q6ZVD8
VIDECVEMATSGQQN

SNRPG

41

P62308
CAAAQENTRVIVEMI

STC2

146

O76061
CEDIAMNFLVANVTG

EXT2

626

Q93063
VQMLLNICSDSQGLE

WDFY4

196

Q6ZS81
VLAQRCLEAGINFMV

MRPL18

131

Q9H0U6
TIGQDLVAMCVNDIL

GART

511

P22102
LVAMCVNDILAQGAE

GART

516

P22102
VMLERQESQDIEGCS

ZNF347

116

Q96SE7
AEMEQASRQCTEALI

TSGA10

306

Q9BZW7
MCNIDVTQQCVIAEI

ATP6V0A4

311

Q9HBG4
VGMAAVQLCRTVENV

VAT1

201

Q99536
QDAMDGELVCRVLQL

XPO7

516

Q9UIA9
LEICFLMAVNVIGQR

PIEZO1

996

Q92508
LEVLGCGVMEQQLVN

FARS2

286

O95363
TVIVMVTRCEEGNRN

PTPRC

746

P08575
NECMQGLEVIESTNL

TRRAP

3096

Q9Y4A5
EQMQVLLDQAGCCIV

TYMP

171

P19971
EEVAQEMVALGLVCE

WNK4

486

Q96J92
FERVEQMCIQIKEVG

TRPM7

1201

Q96QT4
EMTATEGAIVQINCT

TRAV1-2

26

A0A0B4J238
ICVQIVIEMQGFATV

TYW1B

36

Q6NUM6
QCVMANGQEVSEALC

ADAMTSL3

1451

P82987
NMLIDCENQCVIISG

MYO1F

96

O00160
DCVLTSGEIAQIMEQ

NARF

251

Q9UHQ1